Physician profile
Michael Bublik
NPI 1679784664
$4,672.73
in general payments reported to CMS, 2019-2025
13 companies · $235 in 2025
The $235 reported for 2025 was less than what a typical Facial Plastic Surgery provider received nationally (typical 2025 total: $271).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,589 · 2020: $551 · 2021: $553 · 2022: $1,661 · 2023: $83.39 · 2025: $235.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $318.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $318.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,724.78 | 2019-2025 | Scopis Ent, Medline Industries, INC., Xpress Loprofile |
| Medtronic, INC. | $1,474.09 | 2022-2023 | Nuvent |
| Watermark Medical, INC. | $301.42 | 2020 | |
| Aerin Medical INC. | $182.37 | 2019-2022 | |
| Intersect Ent, INC. | $177.07 | 2019-2020 | |
| Acclarent, INC | $174.49 | 2019 | |
| Galderma Laboratories, L.P. | $140.86 | 2019-2023 | |
| Medtronic USA, INC. | $129.90 | 2019 | |
| Optinose US, INC. | $119.78 | 2019 | |
| Carestream Dental, LLC | $83.38 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $80.35 | 2021-2022 | |
| Merz North America, INC. | $46.21 | 2019 | |
| Jubilant Hollisterstier LLC | $38.03 | 2019-2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bublik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.